98 related articles for article (PubMed ID: 3289728)
1. Human squamous cell carcinoma lines express oncofetal 44-kD polypeptide defined by monoclonal antibody to mouse fetus.
Gussack GS; Rohrer SD; Hester RB; Liu PI; Coggin JH
Cancer; 1988 Jul; 62(2):283-90. PubMed ID: 3289728
[TBL] [Abstract][Full Text] [Related]
2. 44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers.
Coggin JH; Rohrer SD; Hester RD; Barsoum AL; Rashid HU; Gussack GS
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1257-66. PubMed ID: 8217085
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal antigen expression in head and neck carcinoma.
Gussack GS
Laryngoscope; 1992 Feb; 102(2):168-76. PubMed ID: 1738289
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical examination of 11 cell lines derived from human head and neck squamous cell carcinomas, their recurrences or metastases.
Koldovsky P; Haas I; Bier H; Ganzer U
Eur Arch Otorhinolaryngol; 1995; 252(6):359-65. PubMed ID: 8679156
[TBL] [Abstract][Full Text] [Related]
5. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
6. Altered antigen expression predicts outcome in squamous cell carcinoma of the head and neck.
Wolf GT; Carey TE; Schmaltz SP; McClatchey KD; Poore J; Glaser L; Hayashida DJ; Hsu S
J Natl Cancer Inst; 1990 Oct; 82(19):1566-72. PubMed ID: 2119437
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced lymphoblastic lymphomas/leukemias and sarcomas of mice express conserved, immunogenic 44-kilodalton oncofetal antigen.
Coggin JH; Rohrer SD; Leinbach ED; Hester RB; Liu PI; Heath LS
Am J Pathol; 1988 Jan; 130(1):136-46. PubMed ID: 3337209
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
Kimmel KA; Carey TE; Judd WJ; McClatchey KD
J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
[TBL] [Abstract][Full Text] [Related]
9. Expression of 44-kilodalton oncofetal antigen as a premalignancy marker in X irradiation-induced murine T-cell lymphoma.
Rohrer SD; Sarli RN; Barsoum AL; Hester RB; Coggin JH
J Natl Cancer Inst; 1992 Apr; 84(8):602-9. PubMed ID: 1556771
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric flow cytometry of human squamous cell carcinoma lines from the head and neck.
Wustrow TP; Raffael A; Valet G
Otolaryngol Head Neck Surg; 1988 Jun; 98(6):552-7. PubMed ID: 3138611
[TBL] [Abstract][Full Text] [Related]
11. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Minn H; Clavo AC; Grénman R; Wahl RL
J Nucl Med; 1995 Feb; 36(2):252-8. PubMed ID: 7830126
[TBL] [Abstract][Full Text] [Related]
12. Expression of A9 antigen and loss of blood group antigens as determinants of survival in patients with head and neck squamous carcinoma.
Carey TE; Wolf GT; Hsu S; Poore J; Peterson K; McClatchey KD
Otolaryngol Head Neck Surg; 1987 Mar; 96(3):221-30. PubMed ID: 3108804
[TBL] [Abstract][Full Text] [Related]
13. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
[TBL] [Abstract][Full Text] [Related]
14. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody.
Bradford CR; Kimmel KA; Van Dyke DL; Worsham MJ; Tilley BJ; Burk D; del Rosario F; Lutz S; Tooley R; Hayashida DJ
Genes Chromosomes Cancer; 1991 Jul; 3(4):272-82. PubMed ID: 1958593
[TBL] [Abstract][Full Text] [Related]
15. Integrins in head and neck squamous cell carcinoma invasion.
Dyce OH; Ziober AF; Weber RS; Miyazaki K; Khariwala SS; Feldman M; Ziober BL
Laryngoscope; 2002 Nov; 112(11):2025-32. PubMed ID: 12439174
[TBL] [Abstract][Full Text] [Related]
16. IL-6 Inhibition With MEDI5117 Decreases The Fraction of Head and Neck Cancer Stem Cells and Prevents Tumor Recurrence.
Finkel KA; Warner KA; Kerk S; Bradford CR; McLean SA; Prince ME; Zhong H; Hurt EM; Hollingsworth RE; Wicha MS; Tice DA; Nör JE
Neoplasia; 2016 May; 18(5):273-281. PubMed ID: 27237319
[TBL] [Abstract][Full Text] [Related]
17. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention.
Fabricius EM; Kruse-Boitschenko U; Schneeweiss U; Wildner GP; Hoffmeister B; Raguse JD
Int J Oncol; 2011 Nov; 39(5):1083-97. PubMed ID: 21785820
[TBL] [Abstract][Full Text] [Related]
18. DNA ploidy and protein synthesis in squamous cell carcinoma cell lines of the head and neck.
Görögh T; Lippert BM; Sprenger E; Saffran S; Heidorn K; Bergmann G; Henze E; Werner JA
J Cancer Res Clin Oncol; 1997; 123(1):39-44. PubMed ID: 8996539
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer.
Kass ES; Greiner JW; Kantor JA; Tsang KY; Guadagni F; Chen Z; Clark B; De Pascalis R; Schlom J; Van Waes C
Cancer Res; 2002 Sep; 62(17):5049-57. PubMed ID: 12208760
[TBL] [Abstract][Full Text] [Related]
20. Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: evaluation as markers of squamous dysplasia.
Piotti KC; Scognamiglio T; Chiu R; Chen YT
Pathol Res Pract; 2013 Nov; 209(11):721-6. PubMed ID: 24011616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
